Cancer patient-centered home care: a new model for health care in oncology
2011-01-01 Tralongo, P; Ferraù, F; Borsellino, N; Verderame, F; Caruso, M; Giuffrida, D; Butera, A; Gebbia, V
Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases
2010-01-01 Zerbi, Alessandro; Null, Null; Capitanio, Vanessa; Boninsegna, Letizia; Pasquali, Claudio; Rindi, Guido; Delle Fave, Gianfranco; Del Chiaro, Marco; Casadei, Riccardo; Falconi, Massimo; Gebbia, Vittorio
Does pain intensity predict a poor opioid response in cancer patients?
2011-01-01 Mercadante, S; Gebbia, V; David, F; Aielli, F; Verna, L; Porzio, G; Ferrera, P; Casuccio, Alessandra; Ficorella, C.
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
2011-01-01 Galetta, D; Gebbia, V; Silvestris, N; Ferraù, F; Carrozza, F; Cigolari, S; Russo, P; Calista, F; Adamo, V; Colucci, G.
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)
2011-01-01 Banna, Giuseppe Luigi; Di Maio, Massimo; Follador, Alessandro; Collovà, Elena; Menis, Jessica; Novello, Silvia; Bria, Emilio; Airoldi, M; Amoroso, D; Ardizzoia, A; Aurilio, G; Bajetta, E; Ballardini, P; Barbieri, F; Barletta, E; Balzelloni, Ml; Basso, U; Bernardini, I; Boni, C; Bordin, V; Bretti, S; Bronte, G; Brunetti, C; Buti, S; Capanna, L; Colombo, A; Condemi, G; Cortinovis, D; Dambrosio, M; Di Fonzo, C; Di Lucca, G; Dima, G; Falzetta, A; Favaretto, A; Ferraù, F; Garetto, L; Gebbia, V; Genestreti, G; Gentile, Al; Giovanardi, F; Labianca, R; Lorusso, V; Mantovani, G; Martelli, O; Massari, F; Mazzoli, M; Michetti, G; Mordenti, P; Mucciarini, C; Munao, S; Nacci, A; Pogliani, C; Procopio, G; Riccardi, F; Rizzato, S; Rossi, A; Rosti, G; Russo, P; Saladino, T; Salesi, N; Santangelo, D; Sava, T; Savarino, A; Spinnato, F; Tiseo, M; Tomassi, O; Tondulli, L; Tonini, G; Turano, S; Valerio, Mr; Verderame, F; Zanelli, F; Zanon, E.
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
2011-01-01 Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Venturini, M
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011-01-01 Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G.
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
2011-01-01 Pignata, Sandro; Scambia, Giovanni; Ferrandina, Gabriella; Savarese, Antonella; Sorio, Roberto; Breda, Enrico; Gebbia, Vittorio; Musso, Pietro; Frigerio, Luigi; Del Medico, Pietro; Lombardi, Alessandra Vernaglia; Febbraro, Antonio; Scollo, Paolo; Ferro, Antonella; Tamberi, Stefano; Brandes, Alba; Ravaioli, Alberto; Valerio, Maria Rosaria; Aitini, Enrico; Natale, Donato; Scaltriti, Laura; Greggi, Stefano; Pisano, Carmela; Lorusso, Domenica; Salutari, Vanda; Legge, Francesco; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)
2011-01-01 Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G.
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel
2011-01-01 Gebbia, Vittorio; Serretta, Vincenzo; Borsellino, N; Valerio, Maria Rosaria
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study
2011-01-01 Gridelli, C; Ardizzoni, A; Barni, S; Crinò, L; Caprioli, A; Piazza, E; Lorusso, V; Barbera, S; Zilembo, N; Gebbia, V; Adamo, V; Pela, R; Marangolo, M; Morena, R; Filippelli, G; Buscarino, C; Alabiso, O; Maione, P; Venturino, P; De Marinis, F
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
2012-01-01 Grossi, F; de Marinis, F; Gebbia, V; Riccardi, F; Caffo, O; Gamucci, T; Ferraù, F; Nardi, M; Moscetti, L; Boni, L; Dondi, D; Galligioni, E.
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma
2012-01-01 Gebbia, Vittorio; Boussen, H.; Valerio, Maria Rosaria
Erlotinib versus standard chemotherapy as fi rst-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
2012-01-01 Rosell, R; Carcereny, E; Gervais, R; Vergnenegre, A; Massuti, B; Felip, E; Palmero, R; Garcia-Gomez, R; Pallares, C; Sanchez, Jm; Porta, R; Cobo, M; Garrido, P; Longo, F; Moran, T; Insa, A; De Marinis, F; Corre, R; Bover, I; Illiano, A; Dansin, E; de Castro, J; Milella, M; Reguart, N; Altavilla, G; Jimenez, U; Provencio, M; Moreno, Ma; Terrasa, J; Muñoz-Langa, J; Valdivia, J; Isla, D; Domine, M; Molinier, O; Mazieres, J; Baize, N; Garcia-Campelo, R; Robinet, G; Rodriguez-Abreu, D; Lopez-Vivanco, G; Gebbia, V; Ferrera-Delgado, L; Bombaron, P; Bernabe, R; Bearz, A; Artal, A; Cortesi, E; Rolfo, C; Sanchez-Ronco, M; Drozdowskyj, A; Queralt, C; de Aguirre, I; Ramirez, Jl; Sanchez, Jj; Molina, Ma; Taron, M; Paz-Ares, L
Spinal analgesia for advanced cancer patients: an update
2011-01-01 Mercadante, S; Porzio, G; Gebbia, V
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents
2012-01-01 Gebbia, Vittorio; Bellavia, G; Ferraù, F; Valerio, Maria Rosaria
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
2012-01-01 Di Maio, M; Signoriello, S; Morabito, A; Rossi, A; Maione, P; Piantedosi, Fv; Bilancia, D; Cigolari, S; Barbera, S; Gebbia, V; Daniele, B; Robbiati, F; Illiano, A; Ceribelli, A; Carrozza, F; Favaretto, A; Piazza, E; Piccirillo, Mc; Daniele, G; Giordano, P; Costanzo, R; Sandomenico, C; Rocco, G; Gallo, C; Perrone, F; Gridelli, C
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial
2012-01-01 Gridelli, C; Ciardiello, F; Gallo, C; Feld, R; Butts, C; Gebbia, V; Maione, P; Morgillo, F; Genestreti, G; Favaretto, A; Leighl, N; Wierzbicki, R; Cinieri, S; Alam, Y; Siena, S; Tortora, G; Felletti, R; Riccardi, F; Mancuso, G; Rossi, A; Cantile, F; Tsao, Ms; Saieg, M; da Cunha Santos, G; Piccirillo, Mc; Di Maio, M; Morabito, A; Perrone, F.
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia
2012-01-01 Serretta, Vincenzo; Altieri, V; Morgia, G.; Nicolosi, F.; De Grande, G.; Mazza, R.; Melloni, Darvinio; Allegro, Rosalinda; Ferraù, F.; Gebbia, Vittorio
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer
2012-01-01 Di Maio, M; Leighl, N; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, Vittorio; Morgillo, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, Mario; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, M; Signoriello, S; Perrone, F; Gridelli, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cancer patient-centered home care: a new model for health care in oncology | 1-gen-2011 | Tralongo, P; Ferraù, F; Borsellino, N; Verderame, F; Caruso, M; Giuffrida, D; Butera, A; Gebbia, V | |
| Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases | 1-gen-2010 | Zerbi, Alessandro; Null, Null; Capitanio, Vanessa; Boninsegna, Letizia; Pasquali, Claudio; Rindi, Guido; Delle Fave, Gianfranco; Del Chiaro, Marco; Casadei, Riccardo; Falconi, Massimo; Gebbia, Vittorio | |
| Does pain intensity predict a poor opioid response in cancer patients? | 1-gen-2011 | Mercadante, S; Gebbia, V; David, F; Aielli, F; Verna, L; Porzio, G; Ferrera, P; Casuccio, Alessandra; Ficorella, C. | |
| Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). | 1-gen-2011 | Galetta, D; Gebbia, V; Silvestris, N; Ferraù, F; Carrozza, F; Cigolari, S; Russo, P; Calista, F; Adamo, V; Colucci, G. | |
| Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) | 1-gen-2011 | Banna, Giuseppe Luigi; Di Maio, Massimo; Follador, Alessandro; Collovà, Elena; Menis, Jessica; Novello, Silvia; Bria, Emilio; Airoldi, M; Amoroso, D; Ardizzoia, A; Aurilio, G; Bajetta, E; Ballardini, P; Barbieri, F; Barletta, E; Balzelloni, Ml; Basso, U; Bernardini, I; Boni, C; Bordin, V; Bretti, S; Bronte, G; Brunetti, C; Buti, S; Capanna, L; Colombo, A; Condemi, G; Cortinovis, D; Dambrosio, M; Di Fonzo, C; Di Lucca, G; Dima, G; Falzetta, A; Favaretto, A; Ferraù, F; Garetto, L; Gebbia, V; Genestreti, G; Gentile, Al; Giovanardi, F; Labianca, R; Lorusso, V; Mantovani, G; Martelli, O; Massari, F; Mazzoli, M; Michetti, G; Mordenti, P; Mucciarini, C; Munao, S; Nacci, A; Pogliani, C; Procopio, G; Riccardi, F; Rizzato, S; Rossi, A; Rosti, G; Russo, P; Saladino, T; Salesi, N; Santangelo, D; Sava, T; Savarino, A; Spinnato, F; Tiseo, M; Tomassi, O; Tondulli, L; Tonini, G; Turano, S; Valerio, Mr; Verderame, F; Zanelli, F; Zanon, E. | |
| Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) | 1-gen-2011 | Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Venturini, M | |
| A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer | 1-gen-2011 | Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G. | |
| Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial | 1-gen-2011 | Pignata, Sandro; Scambia, Giovanni; Ferrandina, Gabriella; Savarese, Antonella; Sorio, Roberto; Breda, Enrico; Gebbia, Vittorio; Musso, Pietro; Frigerio, Luigi; Del Medico, Pietro; Lombardi, Alessandra Vernaglia; Febbraro, Antonio; Scollo, Paolo; Ferro, Antonella; Tamberi, Stefano; Brandes, Alba; Ravaioli, Alberto; Valerio, Maria Rosaria; Aitini, Enrico; Natale, Donato; Scaltriti, Laura; Greggi, Stefano; Pisano, Carmela; Lorusso, Domenica; Salutari, Vanda; Legge, Francesco; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco | |
| Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE) | 1-gen-2011 | Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G. | |
| Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel | 1-gen-2011 | Gebbia, Vittorio; Serretta, Vincenzo; Borsellino, N; Valerio, Maria Rosaria | |
| Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study | 1-gen-2011 | Gridelli, C; Ardizzoni, A; Barni, S; Crinò, L; Caprioli, A; Piazza, E; Lorusso, V; Barbera, S; Zilembo, N; Gebbia, V; Adamo, V; Pela, R; Marangolo, M; Morena, R; Filippelli, G; Buscarino, C; Alabiso, O; Maione, P; Venturino, P; De Marinis, F | |
| A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer | 1-gen-2012 | Grossi, F; de Marinis, F; Gebbia, V; Riccardi, F; Caffo, O; Gamucci, T; Ferraù, F; Nardi, M; Moscetti, L; Boni, L; Dondi, D; Galligioni, E. | |
| Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma | 1-gen-2012 | Gebbia, Vittorio; Boussen, H.; Valerio, Maria Rosaria | |
| Erlotinib versus standard chemotherapy as fi rst-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial | 1-gen-2012 | Rosell, R; Carcereny, E; Gervais, R; Vergnenegre, A; Massuti, B; Felip, E; Palmero, R; Garcia-Gomez, R; Pallares, C; Sanchez, Jm; Porta, R; Cobo, M; Garrido, P; Longo, F; Moran, T; Insa, A; De Marinis, F; Corre, R; Bover, I; Illiano, A; Dansin, E; de Castro, J; Milella, M; Reguart, N; Altavilla, G; Jimenez, U; Provencio, M; Moreno, Ma; Terrasa, J; Muñoz-Langa, J; Valdivia, J; Isla, D; Domine, M; Molinier, O; Mazieres, J; Baize, N; Garcia-Campelo, R; Robinet, G; Rodriguez-Abreu, D; Lopez-Vivanco, G; Gebbia, V; Ferrera-Delgado, L; Bombaron, P; Bernabe, R; Bearz, A; Artal, A; Cortesi, E; Rolfo, C; Sanchez-Ronco, M; Drozdowskyj, A; Queralt, C; de Aguirre, I; Ramirez, Jl; Sanchez, Jj; Molina, Ma; Taron, M; Paz-Ares, L | |
| Spinal analgesia for advanced cancer patients: an update | 1-gen-2011 | Mercadante, S; Porzio, G; Gebbia, V | |
| Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents | 1-gen-2012 | Gebbia, Vittorio; Bellavia, G; Ferraù, F; Valerio, Maria Rosaria | |
| Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials | 1-gen-2012 | Di Maio, M; Signoriello, S; Morabito, A; Rossi, A; Maione, P; Piantedosi, Fv; Bilancia, D; Cigolari, S; Barbera, S; Gebbia, V; Daniele, B; Robbiati, F; Illiano, A; Ceribelli, A; Carrozza, F; Favaretto, A; Piazza, E; Piccirillo, Mc; Daniele, G; Giordano, P; Costanzo, R; Sandomenico, C; Rocco, G; Gallo, C; Perrone, F; Gridelli, C | |
| First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial | 1-gen-2012 | Gridelli, C; Ciardiello, F; Gallo, C; Feld, R; Butts, C; Gebbia, V; Maione, P; Morgillo, F; Genestreti, G; Favaretto, A; Leighl, N; Wierzbicki, R; Cinieri, S; Alam, Y; Siena, S; Tortora, G; Felletti, R; Riccardi, F; Mancuso, G; Rossi, A; Cantile, F; Tsao, Ms; Saieg, M; da Cunha Santos, G; Piccirillo, Mc; Di Maio, M; Morabito, A; Perrone, F. | |
| A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia | 1-gen-2012 | Serretta, Vincenzo; Altieri, V; Morgia, G.; Nicolosi, F.; De Grande, G.; Mazza, R.; Melloni, Darvinio; Allegro, Rosalinda; Ferraù, F.; Gebbia, Vittorio | |
| Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer | 1-gen-2012 | Di Maio, M; Leighl, N; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, Vittorio; Morgillo, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, Mario; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, M; Signoriello, S; Perrone, F; Gridelli, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista16769
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa18
- 2020 - 20278195
- 2010 - 20195973
- 2000 - 20092001
- 1990 - 1999523
- 1980 - 198961
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...246
- JOURNAL OF CLINICAL MEDICINE186
- CANCERS137
- INTERNATIONAL JOURNAL OF ENVIRONM...121
- DIAGNOSTICS88
- LNS. ACTIVITY REPORT85
- SCIENTIFIC REPORTS85
- PHD KORE REVIEW79
- NUTRIENTS78
- RIVISTA DELLA COOPERAZIONE GIURID...76
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19279
- Humans267
- Female142
- Male132
- SARS-CoV-2118
- inflammation111
- oxidative stress89
- Italy87
- Adult73
- Inflammation72
Lingua
- eng11972
- ita2619
- spa68
- fre66
- ger12
- lat12
- por6
- ara3
- cat3
- enm3
Accesso al fulltext
- no fulltext16772